Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study

Vivienne Hillerich (), Frederik Valbert, Silke Neusser, Oliver Pfaar, Ludger Klimek, Annette Sperl, Thomas Werfel, Eckard Hamelmann, Cordula Riederer, Stefanie Wobbe-Ribinski, Anja Neumann, Jürgen Wasem and Janine Biermann-Stallwitz
Additional contact information
Vivienne Hillerich: University Duisburg-Essen
Frederik Valbert: University Duisburg-Essen
Silke Neusser: University Duisburg-Essen
Oliver Pfaar: University Hospital Marburg, Philipps-Universität Marburg
Ludger Klimek: Center for Rhinology and Allergology
Annette Sperl: Center for Rhinology and Allergology
Thomas Werfel: Hannover Medical School
Eckard Hamelmann: University Bielefeld
Cordula Riederer: DAK-Gesundheit
Stefanie Wobbe-Ribinski: DAK-Gesundheit
Anja Neumann: University Duisburg-Essen
Jürgen Wasem: University Duisburg-Essen
Janine Biermann-Stallwitz: University Duisburg-Essen

The European Journal of Health Economics, 2024, vol. 25, issue 4, No 3, 579-600

Abstract: Abstract Background Allergic rhinitis (AR) and allergic asthma (AA) are chronic respiratory diseases that represent a global health problem. One aim of this study was to analyze the Health-related Quality of Life (HRQoL) of the patients in order to identify statistically significant influencing factors that determine HRQoL. Another aim was to assess and analyze data on cost-of-illness from a statutory health insurance perspective. Methods The EQ-5D-5L was used to evaluate the patients’ HRQoL. To identify the factors influencing the HRQoL, a multinomial logistic regression analysis was conducted using groups based on the EQ-5D-5L index value as dependent variable. Routine data were analyzed to determine total healthcare costs. Results The average EQ-5D-5L index was 0.85 (SD 0.20). A high age, the amount of disease costs, low internal health-related control beliefs and high ozone exposure in the residential area were found to be statistically significant influencing factors for a low HRQoL, whereas low age, male sex and a good possibility to avoid the allergens were found to be statistically significant factors influencing a high HRQoL. On average, the study participants incurred annual costs of €3072 (SD: 3485), of which €699 (SD: 743) could be assigned to allergic respiratory diseases. Conclusions Overall, the patients in the VerSITA study showed a high level of HRQoL. The identified influencing factors can be used as starting points for improving the HRQoL of patients with allergic respiratory diseases. From the perspective of a statutory health insurance, per person expenditures for allergic respiratory diseases are rather low.

Keywords: Asthma; Rhinitis; Health Economics; Health-Related Quality of Life; Healthcare Costs (search for similar items in EconPapers)
JEL-codes: I10 I13 I18 I19 (search for similar items in EconPapers)
Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10198-023-01598-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:25:y:2024:i:4:d:10.1007_s10198-023-01598-3

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-023-01598-3

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().